デフォルト表紙
市場調査レポート
商品コード
1328818

デジタル病理システムの世界市場

Digital Pathology Systems

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 620 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
デジタル病理システムの世界市場
出版日: 2023年08月15日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 620 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

デジタル病理システムの世界市場は2030年までに22億米ドルに達する

変化するCOVID-19後のビジネス環境において、2022年に8億1,100万米ドルと推定されるデジタル病理システムの世界市場は、2030年までに22億米ドルの市場規模に改定され、分析期間2022-2030年のCAGR13%で成長すると予測されます。本レポートで分析したセグメントの1つであるデバイスは、CAGR13%を記録し、分析期間終了時には11億米ドルに達すると予測されています。現在進行中のパンデミック後の回復を考慮し、ソフトウェア分野の成長は今後8年間のCAGRを13.7%に修正しました。

米国市場は3億5,370万米ドル、中国はCAGR 14.1%で成長すると予測

米国のデジタル病理システム市場は、2022年には3億5,370万米ドルになると推定されます。世界第2位の経済大国である中国は、2022年から2030年のCAGR14.1%で、2030年までに1億7,790万米ドルの市場規模に達すると予測されています。その他の注目すべき地理的市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ10.1%と11.8%の成長が予測されています。欧州では、ドイツがCAGR約11.8%で成長すると予測されています。オーストラリア、インド、韓国などの国々が牽引するアジア太平洋市場は、2030年までに1億370万米ドルに達すると予測されています。

調査対象企業の例

  • Danaher Corporation
  • Cerner Corporation
  • Barco NV
  • Nikon Corporation
  • Nikon Instruments, Inc.
  • Koninklijke Philips N.V.
  • A. Menarini Diagnostics Srl
  • Leica Biosystems Nussloch GmbH
  • MD Biosciences, Inc.
  • Euromex Microscopen BV
  • Apollo Enterprise Imaging Corporation
  • Indica Labs, Inc.
  • Inspirata, Inc.
  • Mikroscan Technologies, Inc.
  • Leica Mikrosysteme Vertrieb GmbH Mikroskopie und Histologie

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-6740

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Digital Pathology Systems Market to Reach $2.2 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Digital Pathology Systems estimated at US$811 Million in the year 2022, is projected to reach a revised size of US$2.2 Billion by 2030, growing at a CAGR of 13% over the analysis period 2022-2030. Device, one of the segments analyzed in the report, is projected to record a 13% CAGR and reach US$1.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Software segment is readjusted to a revised 13.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $353.7 Million, While China is Forecast to Grow at 14.1% CAGR

The Digital Pathology Systems market in the U.S. is estimated at US$353.7 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$177.9 Million by the year 2030 trailing a CAGR of 14.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.1% and 11.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 11.8% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$103.7 Million by the year 2030.

Select Competitors (Total 74 Featured) -

  • Danaher Corporation
  • Cerner Corporation
  • Barco NV
  • Nikon Corporation
  • Nikon Instruments, Inc.
  • Koninklijke Philips N.V.
  • A. Menarini Diagnostics Srl
  • Leica Biosystems Nussloch GmbH
  • MD Biosciences, Inc.
  • Euromex Microscopen BV
  • Apollo Enterprise Imaging Corporation
  • Indica Labs, Inc.
  • Inspirata, Inc.
  • Mikroscan Technologies, Inc.
  • Leica Mikrosysteme Vertrieb GmbH Mikroskopie und Histologie

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • COVID-19 Ushers in 2020 as the Year of Healthcare Digitalization
    • Global Venture Capital Investments in Digital Health Startups (In US$ Billion)
    • % Share VC Investments by Category for 2020
    • FDA Temporarily Relaxes Guidelines to Promote Remote Digital Pathology Services amid COVID-19 Pandemic
    • COVID-19 Highlights Need to Implement Structured Online Curriculum for Pathology Training
    • Future Outlook of Pathology Post-COVID-19
    • Digital Pathology Systems - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Digital Pathology: An Introduction
    • Key Digital Pathology Tools
    • Market Outlook
    • US and Europe Maintain Dominance
    • Emerging Markets to Experience Strong Growth
    • Scanners Lead Digital Pathology Market
    • Software Segment Post Strong Growth
    • Disease Diagnosis: Major Application of Digital Pathology Systems
    • Telepathology Experiences Strong Growth
    • Pharmaceutical and Biotechnology Companies: Important End Use Markets for Digital Pathology
    • Global Digital Pathology Systems Market by End-Use: 2020
    • Major Issues Hampering Adoption of Digital Pathology Systems
    • Competitive Landscape
    • Market Share of Leading Players in Digital Pathology Systems Market: 2020E
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Technological Advancements Drive Adoption of Digital Pathology Systems
    • Artificial Intelligence (AI) Steps in to Widen the Scope & Span of Digital Pathology
    • EXIBIT: AI Spending in Healthcare & Lifesciences in US$ Million for Years 2020 & 2025
    • Advantages of AI-Powered Digital Pathology
    • Digital Pathology Benefits Drug Discovery Process
    • Need for Early Diagnosis Puts Focus on Digital Pathology
    • Digital Pathology Systems See Fast Paced Adoption in Cancer and Other Chronic Diseases
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Number of New Cancer Cases and Deaths (in Million) by Region for 2018
    • Global New Cancer Cases and Cancer-related Deaths by Cancer Site (in %) for 2018
    • Digital Pathology Emerges as a Tool to Reduce Cases of Cancer Misdiagnoses
    • Scarcity of Pathologists & Excess Workload on Pathology Labs Drives Demand for Digital Systems
    • Clinical Research Continues to be Core Vertical for Digital Pathology
    • Digital Imaging and Robotic Light Microscopy Boost Growth
    • Computational Pathology for Leading-Edge Image Analytics
    • Cloud Platform Gains Momentum
    • Telepathology Expected to Pave Way for Pathology Outsourcing to Developing Nations
    • Rise in Significance of Personalized Medicine Bodes Well for Digital Pathology
    • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019 and 2024
    • Increased Focus on Companion Diagnostics to Benefit Market Growth
    • Improving Healthcare & Research Expenditure to Support Growth
    • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • Aging Population: A Key Opportunity Indicator
    • Global Aging Population: Population of 65+ Individuals (in Thousands) by Region for 2019 and 2030
    • Global Population of 65+ Individuals as % of Total Population by Region for 2019 and 2030
    • Global Cancer Deaths by Age Group (in %) for 2019
    • Challenges Facing Digital Pathology Systems Market
    • High Costs
    • Workflow Integration with Other Related Functions
    • Other Issues
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Digital Pathology Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Digital Pathology Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 3: World 15-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 6: World 15-Year Perspective for Device by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 9: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 12: World 15-Year Perspective for Other Segments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Human Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Human Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 15: World 15-Year Perspective for Human Pathology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Veterinary Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Veterinary Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 18: World 15-Year Perspective for Veterinary Pathology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 21: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Hospitals & Reference Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Hospitals & Reference Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 24: World 15-Year Perspective for Hospitals & Reference Labs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 27: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2023 & 2030
    • TABLE 28: World Digital Pathology Systems Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • COVID-19 Triggers Demand for Digital Pathology
    • Market Overview
    • Increasing Pressure on Pathological Labs: Cornerstone for Growth
    • TABLE 29: USA Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • JAPAN
    • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • Market Overview
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • CHINA
    • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • Market Overview
    • TABLE 56: China Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 58: China 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 61: China 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 64: China 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • EUROPE
    • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • Market Overview
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Digital Pathology Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Digital Pathology Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2023 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • FRANCE
    • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 79: France 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 82: France 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 85: France 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • GERMANY
    • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • UNITED KINGDOM
    • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • ASIA-PACIFIC
    • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • Market Overview
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Digital Pathology Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Digital Pathology Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2023 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • AUSTRALIA
    • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • INDIA
    • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • Market Overview
    • Inadequate Infrastructure Impedes Adoption of Telepathology
    • TABLE 161: India Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 163: India 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 166: India 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 169: India 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • LATIN AMERICA
    • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Digital Pathology Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Digital Pathology Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2023 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • MIDDLE EAST
    • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Digital Pathology Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Digital Pathology Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2023 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030
  • AFRICA
    • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2023 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2023 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2021 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2023 & 2030

IV. COMPETITION